Sintofarm S.p.A., a prominent player in the pharmaceutical industry, is headquartered in Italy and operates extensively across Europe and beyond. Founded in 1982, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of oncology and pain management. With a commitment to innovation, Sintofarm S.p.A. offers a diverse range of core products, including advanced formulations and generics that cater to the evolving needs of healthcare professionals and patients. The company’s dedication to quality and efficacy has earned it a strong market position, recognised for its contributions to improving patient outcomes. Through strategic partnerships and a focus on research and development, Sintofarm continues to achieve significant milestones in the pharmaceutical landscape.
How does Sintofarm S.p.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sintofarm S.p.A.'s score of 18 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sintofarm S.p.A., headquartered in Italy, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges available, suggesting that the company may not have established formal commitments to reduce its carbon footprint at this time. Given the lack of specific emissions data and reduction initiatives, it is unclear how Sintofarm S.p.A. aligns with industry standards for climate action. The absence of information on emissions and climate commitments may reflect a broader trend within the industry, where companies are increasingly being urged to disclose their environmental impact and set measurable targets for reduction. As the global focus on sustainability intensifies, it is essential for organisations like Sintofarm S.p.A. to consider developing and communicating clear climate strategies to enhance transparency and accountability in their environmental practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sintofarm S.p.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
